Information about Holding Isabelle Bauwens Pharma Group
My details
*
*
*

Holding Isabelle Bauwens Pharma Group (SRL)

BE 1036.132.224

Korte Heesdonkstraat 32, 9250 Waasmunster

Company information

Status
Active

Enterprise number

BE1036.132.224

VAT liability
No
Established
27-03-2026
Last balance sheet year
N/A
Company size
N/A 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Publications from Holding Isabelle Bauwens Pharma Group

Date Publication
31-03-2026 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the enterprise number of Holding Isabelle Bauwens Pharma Group?
The enterprise number of Holding Isabelle Bauwens Pharma Group is BE 1036.132.224.
Wat is the PEPPOL ID of Holding Isabelle Bauwens Pharma Group?
There is no information available about the PEPPOL ID of Holding Isabelle Bauwens Pharma Group or the company is not yet registered on the PEPPOL network.
When was Holding Isabelle Bauwens Pharma Group founded?
Holding Isabelle Bauwens Pharma Group was founded on 27-03-2026.
What is the address of Holding Isabelle Bauwens Pharma Group?
The current registered office of Holding Isabelle Bauwens Pharma Group is located at Korte Heesdonkstraat 32, 9250 Waasmunster.
When was the last time Holding Isabelle Bauwens Pharma Group filed their annual financial statements?
Holding Isabelle Bauwens Pharma Group has not (yet) filed any financial statements.
How many employees does Holding Isabelle Bauwens Pharma Group have?
Holding Isabelle Bauwens Pharma Group has not (yet) filed any financial statements or no staff information is available.
What is the annual turnover of Holding Isabelle Bauwens Pharma Group?
There is no turnover available for Holding Isabelle Bauwens Pharma Group.

Sources